(R)-3-(Boc-amino)piperidine - CAS 309956-78-3
Catalog: |
BB020779 |
Product Name: |
(R)-3-(Boc-amino)piperidine |
CAS: |
309956-78-3 |
Synonyms: |
Carbamic acid, N-(3R)-3-piperidinyl-, 1,1-dimethylethyl ester; 1,1-Dimethylethyl N-(3R)-3-piperidinylcarbamate; Carbamic acid, (3R)-3-piperidinyl-, 1,1-dimethylethyl ester; (3R)-3-[((tert-Butyloxycarbonyl)amino)]piperidine; (R)-3-(N-Boc-amino) piperidine; (R)-3-(tert-Butoxycarbonylamino)piperidine; (R)-3-[(tert-Butoxycarbonyl)amino]piperidine; (R)-3-[(tert-Butyloxycarbonyl)amino]piperidine; (R)-3-[N-(tert-Butoxycarbonyl)amino]piperidine; (R)-3-tert-Butoxycarbonylaminopiperidine; (R)-Piperidin-3-ylcarbamic acid tert-butyl ester; (R)-tert-Butyl (piperidin-3-yl)carbamate; tert-Butyl (R)-N-(3-piperidyl)carbamate; tert-Butyl (R)-N-(piperidin-3-yl)carbamate; tert-Butyl (R)-piperidin-3-ylcarbamate; tert-Butyl N-((3R)-3-piperidyl)carbamate |
Related CAS: | 2673329-29-6 (Deleted CAS)
|
IUPAC Name: | tert-butyl N-[(3R)-piperidin-3-yl]carbamate |
Description: | (R)-3-(Boc-amino)piperidine is an impurity of Alogliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor in the class of oral antidiabetic drugs. |
Molecular Weight: | 200.28 |
Molecular Formula: | C10H20N2O2 |
Canonical SMILES: | CC(C)(C)OC(=O)NC1CCCNC1 |
InChI: | InChI=1S/C10H20N2O2/c1-10(2,3)14-9(13)12-8-5-4-6-11-7-8/h8,11H,4-7H2,1-3H3,(H,12,13)/t8-/m1/s1 |
InChI Key: | WUOQXNWMYLFAHT-MRVPVSSYSA-N |
Boiling Point: | 304.8±31.0 °C at 760 mmHg |
Melting Point: | 120-122°C |
Purity: | 98.0% |
Density: | 1.02±0.1 g/cm3 |
Solubility: | Soluble in DMSO, Ethanol, Methanol |
Appearance: | White to Off-white Solid |
Storage: | Store at -20°C |
MDL: | MFCD03093382 |
LogP: | 1.98280 |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P271, P273, P280, P302+P352, P304+P340, P305+P351+P338, P310, P312, P321, P332+P313, P337+P313, P362, P391, P403+P233, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
CN-113061137-A | Nitrogen-containing heterocyclic derivative or pharmaceutically acceptable salt and application thereof | 20210402 |
CN-113004246-A | 1,3, 5-triazine-2-amine-4, 6 substituted derivative or pharmaceutically acceptable salt and application thereof | 20210222 |
CN-112552299-A | Preparation method of linagliptin for treating type II diabetes | 20201225 |
CN-112694465-A | Novel preparation process of trelagliptin succinate | 20201222 |
CN-112759576-A | Novel preparation process of alogliptin benzoate | 20201221 |
Complexity: | 199 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 1 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 200.152477885 |
Formal Charge: | 0 |
Heavy Atom Count: | 14 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 200.152477885 |
Rotatable Bond Count: | 3 |
Topological Polar Surface Area: | 50.4 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 1.1 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Amines and Anilines
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS